Life Science is a sector in full swing. Investors and partnerships between ambitious start-ups, scale-ups and established market players in biotech drive innovation.
However, the road to innovation is not without challenges. In drug development, biotech companies face: 

• ever-stricter regulations that can slow down time-to-market; 
• significant investment in time and money for clinical trials for medicinal products and medical devices 
• an uncertain ROI due to pressure on prices of new medical treatments and therapies 
• the laborious search for new employees who are specialists in their field.